Johnson, R.J., Kanbay, M., Kang, D.-H., Sa′nchez-Lozada, L.G., Room, D.F. and Aurora (2011) Uric Acid A Clinically Useful Marker to Distinguish Preeclampsia From Gestational Hypertension. Hypertension, 58, 548-549.
https://doi.org/10.1161/HYPERTENSIONAHA.111.178921

has been cited by the following article:

• TITLE: Relationship between Uricemia and Other Biochemical Markers with the Materno-Fetal Complications during Pre-Eclampsia

  AUTHORS: B. D. Tshibuela, N. N. Kayembe, M. J. Muwonga, N. K. Nganga, N. Ngole, J. P. Elongi

  KEYWORDS: Uricemia, Biochemical Markers, Maternal-Fetal Complications, Pre-Eclampsia

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.7 No.13, December 19, 2017

  ABSTRACT: Goal: Determining the place of Uricemia associated with other biochemical makers in the prediction of fetal-maternal complications during preeclampsia. Material and method: This is a prospective, cross-sectional study of 75 pre-eclamptic women in three maternities in Kinshasa, Democratic Republic of Congo, during the January to December 2013. The values of the following biochemical markers: uricemia, proteinuria and creatinemia were correlated with maternal and fetal prognosis. Results: This study showed that hyper uricemia associated with massive proteinuria and a high creatinine level correlated with an unfavorable pregnancy outcome and the occurrence of major materno-fetal complications such as eclampsia (X-squared = 24.3598, ddl = 2, p-value = 0.000005) and low birth weight (p = 0.001, R2 = 0.08). Conclusion: In view of these results, it appears necessary to ensure these biochemical markers systematically in the monitoring of pre-eclampsia.